← SynDRA
SU-9516
SynDRA canonical compound SYN0008992 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | CCND1 | CDK1 | CDK2 | CDK4 | CDK5 |
|---|
| Mechanism of action | CDK inhibitor |
|---|
All known targets
- CDK2
- CDK1
- CDK5
- CCND1
- CDK4
Mechanisms of action (all sources)
- CDK2 INHIBITOR
- Cyclin-dependent kinase 2 inhibitor
- cyclin-dependent kinase inhibitor
- CDK5 INHIBITOR
- CDK1 BINDER
Cross-references
Synonyms
- Su9516
- SU9516
- AC1NRD9P
- (3Z)-3-(1H-IMIDAZOL-5-YLMETHYLENE)-5-METHOXY-1H-INDOL-2(3H)-ONE
- (Z)-3-((1H-imidazol-5-yl)methylene)-5-methoxyindolin-2-one
- (3Z)-3-(1H-imidazol-5-ylmethylidene)-5-methoxy-2,3-dihydro-1H-indol-2-one
- 3-[1-(3H-Imidazol-4-yl)-meth-(Z)-ylidene]-5-methoxy-1,3-dihydro-indol-2-one
- SU9
- (Z)-1,3-DIHYDRO-3-(1H-IMIDAZOL-4-YLMETHYLENE)-5-METHOXY-2H-INDOL-2-ONE
- 3py1
- 3py0
- imidazole indolinone driv.
- MLS001074893
- SCHEMBL1170686
- BDBM7238
- SCHEMBL1170687
- CHEMBL258805
- SU 9516
- FD2SWT2SDI
- RefChem:186193
- DTXCID00881795
- (Z)-3-((1H-imidazol-4-yl)methylene)-5-methoxyindolin-2-one
- 3-((1H-Imidazol-5-yl)methylene)-5-methoxyindolin-2-one
- MFCD17010284
- GTPL6045
- orb1301017
- REGID_for_CID_659436
- SCHEMBL19424245
- SCHEMBL29705821
- cid_5289419
- BRD3909
- EX-A523
- CHEBI:113546
- REGID_for_CID_5289419
- GLXC-05786
- HMS2234A17
- HMS3229O20
- BRD-3909
Look up SU-9516 in the interactive SynDRA portal →